The present invention concerns the use of a sphingoid-polyalkylamine
conjugate comprising a sphingoid backbone carrying, via a carbamoyl bond,
at least one polyalkylamine chains as a capturing agent of nucleic acid
molecules. The present invention also provides the use of the sphingoid
polyalkylamine conjugate for the preparation of a pharmaceutical
composition for the delivery of a nucleic acid molecule into a target
cell. In a further aspect the invention provides a method for
transfecting a nucleic acid into a target cell, the method comprises
contacting said target cell with the sphingoid-polyalkylamine conjugate
associated with a nucleic acid molecule, thereby transfecting said target
cell with said nucleic acid molecule. Other aspects of the invention
concern pharmaceutical compositions comprising said conjugate,
therapeutic methods as well as kits, making use of the said conjugate. A
preferred conjugate according to the invention is N-palmitoyl
D-erythrosphingosyl-1-carbamoyl spermine.